I've published a new piece exploring the overlap between dissociation, borderline personality disorder, opioid signaling, and why slow, continuous transdermal buprenorphine may help a subset of patients.
If you're plural and don't identify with BPD but feel that dissociation itself is overwhelming or disruptive, I also discuss ultra-low-dose naltrexone (off-label use) and how subtle opioid modulation may improve internal communication, attention, body awareness, affect tolerance, and self-regulation. This isn't widely discussed and I've been meaning to share it.
I go into depth about why transdermal buprenorphine may offer steadier baseline stabilization than naltrexone, and how that shift in baseline regulation may change what's possible in therapy. This isn't a first-line or well-established treatment, but I share a hopeful anecdote at the end about symptom improvement in a friend with BPD and OSDD/DID.
All of my work is independent and self-funded. There's a "Support this work" link on the site if you'd like to contribute.
I'm working on a PCP guide and patient companion guide next.
https://bpd.fyi/did-and-bpd
#BPD #Dissociation #Trauma #Psychiatry #Neuroscience #MentalHealth